World's Best Scientists 2026 revealed!
Hans-Georg Rammensee

Hans-Georg Rammensee

D-Index & Metrics

Immunology

D-Index
126
Citations
68628
World Ranking
266
National Ranking
13

Medicine

D-Index
127
Citations
69025
World Ranking
2807
National Ranking
145

Hans-Georg Rammensee publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hans-Georg Rammensee sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 608 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hans-Georg Rammensee D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hans-Georg Rammensee sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 126 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 1996 - Paul Ehrlich and Ludwig Darmstaedter Prize
  • 1993 - Robert Koch Prize

Overview

Hans-Georg Rammensee is affiliated with the University of Tübingen in Germany. Their research spans multiple fields, primarily focusing on Medicine and Biochemistry, Genetics and Molecular Biology. Within these fields, their work extensively covers subfields such as Infectious Diseases, Molecular Biology, and Pathology and Forensic Medicine.

Their research topics include SARS-CoV-2 and COVID-19 studies, COVID-19 clinical research, vaccines and immunoinformatics approaches, SARS-CoV-2 detection and testing, chromatin remodeling and cancer, protein degradation and inhibitors, as well as cancer mechanisms and therapy.

Several frequent co-authors have collaborated with them, including:

  • Juliane S. Walz
  • Annika Nelde
  • Jonas S. Heitmann
  • Andreas Peter
  • Sebastian Hörber

Their publications appear regularly in venues such as:

  • Nature Immunology
  • Nature Communications
  • Journal for ImmunoTherapy of Cancer
  • Immunogenetics

Notable recent papers include:

  • "SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition" (2020, Nature Immunology)
  • "Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity" (2021, Nature Communications)
  • "Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors" (2021, Journal for ImmunoTherapy of Cancer)
  • "Kirsten Falk 1963-2024" (2025, Immunogenetics)

Throughout their career, Hans-Georg Rammensee has received awards including the Paul Ehrlich and Ludwig Darmstaedter Prize in 1996 and the Robert Koch Prize in 1993.

Best Publications

  • Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.

    K Falk;O Rötzschke;S Stevanović;G Jung

  • SYFPEITHI: database for MHC ligands and peptide motifs.

    H. G. Rammensee;J. Bachmann;N. P. N. Emmerich;O. A. Bachor

  • Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

    Matthew M. Gubin;Xiuli Zhang;Heiko Schuster;Etienne Caron

  • MHC ligands and peptide motifs: first listing.

    Hans-Georg Rammensee;Thomas Friede;Stefan Stevanović

  • Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

    Steffen Walter;Toni Weinschenk;Arnulf Stenzl;Romuald Zdrojowy

  • Peptides Naturally Presented by MHC Class I Molecules

    Hans-Georg Rammensee;Kirsten Falk;Olaf Rotzschke

  • Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.

    Olaf Rötzschke;Kirsten Falk;Karl Deres;Hansjörg Schild

  • Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

    Hermann Einsele;Eddy Roosnek;Nathalie Rufer;Christian Sinzger

  • Actively personalized vaccination trial for newly diagnosed glioblastoma

    Norbert Hilf;Sabrina Kuttruff-Coqui;Katrin Frenzel;Valesca Bukur

  • In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

    Karl Deres;Hansjörg Schild;Karl-Heinz Wiesmüller;Günther Jung

  • Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.

    U D Staerz;H G Rammensee;J D Benedetto;M J Bevan

  • Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

    Helmut R. Salih;Hans-Georg Rammensee;Alexander Steinle

  • Autophagy promotes MHC class II presentation of peptides from intracellular source proteins

    Jörn Dengjel;Oliver Schoor;Rainer Fischer;Michael Reich

  • Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

    Helmut Rainer Salih;Holger Antropius;Friederike Gieseke;Stefan Zoltan Lutz

  • In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies.

    Ingmar Hoerr;Reinhard Obst;Hans-Georg Rammensee;Günther Jung

  • The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy

    Harpreet Singh-Jasuja;Niels P. N. Emmerich;Hans-Georg Rammensee

  • The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway.

    Ramunas M Vabulas;Sibylla Braedel;Norbert Hilf;Harpreet Singh-Jasuja

  • Clonal anergy induced in mature Vβ6 + T lymphocytes on immunizing Mls-1 b mice with Mls-1 a expressing cells

    Hans-Georg Rammensee;Ruth Kroschewski;Bernard Frangoulis

  • SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.

    Annika Nelde;Tatjana Bilich;Jonas S. Heitmann;Yacine Maringer

  • Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas

    Jörn Dengjel;Maria-Dorothea Nastke;Cécile Gouttefangeas;Gitsios Gitsioudis

  • Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies

    Peter Brossart;Kathrin S. Heinrich;Gernot Stuhler;Lars Behnke

Frequent Co-Authors

Stefan Stevanovic
Stefan Stevanovic University of Tübingen
Lothar Kanz
Lothar Kanz University of Tübingen
Hansjörg Schild
Hansjörg Schild Johannes Gutenberg University of Mainz
Arnulf Stenzl
Arnulf Stenzl University of Tübingen
Peter Brossart
Peter Brossart University Hospital Bonn
Rupert Handgretinger
Rupert Handgretinger University of Tübingen
Oliver Kohlbacher
Oliver Kohlbacher University of Tübingen
Pierre-Yves Dietrich
Pierre-Yves Dietrich University of Geneva
Christian Münz
Christian Münz University of Zurich
Günther Jung
Günther Jung University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many opt for accelerated nursing pathways, such as programs considered the easiest absn program to get into. These programs allow individuals with a non-nursing background to fast-track their Bachelor of Science in Nursing (BSN) credentials.

Entry-level options like Licensed Practical Nurse (LPN) programs also play a crucial role in building clinical experience. Programs with lpn programs with easiest admission requirements offer accessible pathways to healthcare careers while still providing foundational knowledge beneficial to immunology-related roles.

For advanced practice, learners often explore nurse practitioner degrees. Identifying the what is the easiest np program can help in selecting a program that balances admission criteria with comprehensive training in patient care.

Specializing further, psychiatric mental health nurse practitioner roles are in demand. Many students choose programs recognized as the best online pmhnp programs due to their strong clinical placement rates, which enhance hands-on experience crucial for career advancement.

Best Scientists Citing Hans-Georg Rammensee

Trending Scientists

Recently Published Articles